000124445 001__ 124445
000124445 005__ 20240228145515.0
000124445 0247_ $$2doi$$a10.1002/mrm.26369
000124445 0247_ $$2pmid$$apmid:27529579
000124445 0247_ $$2ISSN$$a0740-3194
000124445 0247_ $$2ISSN$$a1522-2594
000124445 0247_ $$2altmetric$$aaltmetric:10632877
000124445 037__ $$aDKFZ-2017-01322
000124445 041__ $$aeng
000124445 082__ $$a610
000124445 1001_ $$0P:(DE-He78)4e04dcea1b6a4449a8fa005bcf36322b$$aStraub, Sina$$b0$$eFirst author$$udkfz
000124445 245__ $$aSuitable reference tissues for quantitative susceptibility mapping of the brain.
000124445 260__ $$aNew York, NY [u.a.]$$bWiley-Liss$$c2017
000124445 3367_ $$2DRIVER$$aarticle
000124445 3367_ $$2DataCite$$aOutput Types/Journal article
000124445 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1511254181_9921
000124445 3367_ $$2BibTeX$$aARTICLE
000124445 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000124445 3367_ $$00$$2EndNote$$aJournal Article
000124445 520__ $$aSince quantitative susceptibility mapping (QSM) quantifies magnetic susceptibility relative to a reference value, a suitable reference tissue has to be available to compare different subjects and stages of disease.To find such a suitable reference tissue for QSM of the brain, melanoma patients with and without brain metastases were measured. Twelve reference regions were chosen and assessed for stability of susceptibility values with respect to multiple intra-individual and inter-individual measurements, age, and stage of disease.Cerebrospinal fluid (CSF), the internal capsule and one region in the splenium of the corpus callosum are the regions with the smallest standard deviations of the mean susceptibility value. The mean susceptibility is 0.010 ± 0.014 ppm for CSF in the atrium of the lateral ventricles (csfpost ), -0.060 ± 0.019 ppm for the posterior limb of the internal capsule (ci2), and -0.008 ± 0.019 ppm for the splenium of the corpus callosum. csfpost and ci2 show nearly no dependence on age or stage of disease, whereas some other regions, e.g., the red nucleus, show moderate dependence on age or disease.The internal capsule and CSF appear to be the most suitable reference regions for QSM of the brain in the melanoma patients studied. Both showed virtually no dependence on age or disease and small variations among patients. Magn Reson Med 78:204-214, 2017. © 2016 International Society for Magnetic Resonance in Medicine.
000124445 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000124445 588__ $$aDataset connected to CrossRef, PubMed,
000124445 7001_ $$0P:(DE-He78)82c2b7c6cf14cf300b561faf9f46818d$$aSchneider, Till$$b1$$udkfz
000124445 7001_ $$0P:(DE-He78)cb524d7857f62988258612fc095c2ae0$$aEmmerich, Julian$$b2$$udkfz
000124445 7001_ $$0P:(DE-He78)c420f6efccb409e1a287be027501a74c$$aFreitag, Martin$$b3$$udkfz
000124445 7001_ $$0P:(DE-He78)a56941777fbaf0ca1008366e7e16667f$$aZiener, Christian$$b4$$udkfz
000124445 7001_ $$0P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec$$aSchlemmer, Heinz-Peter$$b5$$udkfz
000124445 7001_ $$0P:(DE-He78)022611a2317e4de40fd912e0a72293a8$$aLadd, Mark$$b6$$udkfz
000124445 7001_ $$0P:(DE-He78)b709e6df1ec6b63e5ffad4c8131f6f4d$$aLaun, Frederik$$b7$$eLast author$$udkfz
000124445 773__ $$0PERI:(DE-600)1493786-4$$a10.1002/mrm.26369$$gVol. 78, no. 1, p. 204 - 214$$n1$$p204 - 214$$tMagnetic resonance in medicine$$v78$$x0740-3194$$y2017
000124445 909CO $$ooai:inrepo02.dkfz.de:124445$$pVDB
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4e04dcea1b6a4449a8fa005bcf36322b$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)82c2b7c6cf14cf300b561faf9f46818d$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)cb524d7857f62988258612fc095c2ae0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c420f6efccb409e1a287be027501a74c$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a56941777fbaf0ca1008366e7e16667f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)022611a2317e4de40fd912e0a72293a8$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000124445 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b709e6df1ec6b63e5ffad4c8131f6f4d$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000124445 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000124445 9141_ $$y2017
000124445 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000124445 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMAGN RESON MED : 2015
000124445 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000124445 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000124445 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000124445 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000124445 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000124445 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000124445 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000124445 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000124445 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000124445 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000124445 9201_ $$0I:(DE-He78)E020-20160331$$kE020$$lMedizinische Physik in der Radiologie$$x0
000124445 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lRadiologie$$x1
000124445 980__ $$ajournal
000124445 980__ $$aVDB
000124445 980__ $$aI:(DE-He78)E020-20160331
000124445 980__ $$aI:(DE-He78)E010-20160331
000124445 980__ $$aUNRESTRICTED